Kazuhiro Okuda

Dr. Kazuhiro Okuda


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Journal of Periodontology
Verified
Journal Article
Closed access
KOKazuhiro Okuda
Kazuhiro Okuda
TKTomoyuki Kawase
Tomoyuki Kawase
MMManabu Momose
Manabu Momose
MMMasashi Murata
Masashi Murata
YSYoshinori Saito
Yoshinori Saito
HYHiromasa Yoshie
Hiromasa Yoshie
Background: Platelet‐rich plasma (PRP) is a fraction of plasma, in which platelet‐derived growth factor (PDGF) and transforming growth factor‐β(TGF‐β) are thought to be concentrated. It is plausible that topically‐applied PRP up‐regulates cellular activity and subsequently promotes periodontal regeneration in vivo. However, the concentrations of these growth factors in PRP have not been specifically determined and the biological effects PRP at the cellular and molecular levels have not been determined.Methods: PRP obtained from 20 healthy subjects was prepared from plasma by centrifugation. These PRP preparations were immediately subjected to an evaluation for PDGF‐AB and TGF‐β1 using enzyme‐linked immunosorbent assay (ELISA) kits. The biological effects of the PRP preparations were evaluated on osteoblastic, epithelial, fibroblastic, and periodontal ligament cells. Cellular mitogenic activity was evaluated by counting cell numbers or evaluating 5‐bromodeoxyuridine (BrdU) incorporation. Expression of alkaline phosphatase (ALP) was immunocytochemically evaluated.Results: In the PRP preparations, platelets were concentrated up to 70.9 104 cells/μl (283.4% of the unconcentrated plasma). The levels of PDGFAB and TGF‐β1 were also concentrated up to 182.0 ng/ml (440.6%) and 140.9 ng/ml (346.6%), respectively. Scatter plots revealed significant correlations between platelet counts and levels of these growth factors. PRP stimulated osteoblastic DNA synthesis and cell division (138% of control), with simultaneous down‐regulation of ALP, but suppressed epithelial cell division (80% of control). PRP also stimulated DNA synthesis in gingival fibroblasts and periodontal ligament cells.Conclusions: These data demonstrated that both PDGF‐AB and TGF‐β1 were highly concentrated in the PRP preparations. It is suggested PRP modulates cell proliferation in a cell type‐specific manner similar to what has been observed with TGF‐β1. Since synchronized behavior of related cell types is thought to be required for successful periodontal regeneration, it is further suggested these cell type‐specific actions may be beneficial for periodontal regenerative therapy. J Periodontol 2003;74:849‐857.

1 June 2005 in Journal of Periodontology
Verified
Journal Article
Closed access
KOKazuhiro Okuda
Kazuhiro Okuda
HTHideaki Tai
Hideaki Tai
KTKiyoshi Tanabe
Kiyoshi Tanabe
HSHironobu Suzuki
Hironobu Suzuki
TSTadashi Sato
Tadashi Sato
HYHiromasa Yoshiex
Hiromasa Yoshiex
Background: The aim of the present controlled clinical study was to compare platelet‐rich plasma (PRP) combined with a biodegradable ceramic, porous hydroxyapatite (HA) with a mixture of HA and saline in the treatment of human intrabony defects.Methods: Seventy interproximal intrabony osseous defects in 70 healthy, non‐smoking subjects diagnosed with chronic periodontitis were included in this study. Thirty‐five subjects each were randomly assigned to either the test group (PRP and HA) or control group (HA with saline). Clinical and radiographic measurements were determined at baseline and the 12‐month evaluation.Results: When compared to baseline, the 12‐month results indicated that, while both treatment modalities resulted in significant changes in all clinical parameters (gingival index, bleeding on probing, probing depth, clinical attachment level, and intrabony defect fill; P <0.001), the test group exhibited statistically significant changes compared to the control sites in probing depth reduction: 4.7 ± 1.6 mm versus 3.7 ± 2.0 mm (P <0.05); clinical attachment gain: 3.4 ± 1.7 mm versus 2.0 ± 1.2 mm (P <0.001); and vertical relative attachment gain: 70.3% ± 23.4% versus 45.5% ± 29.4% (P <0.001).Conclusion: Treatment with a combination of PRP and HA compared to HA with saline led to a significantly more favorable clinical improvement in intrabony periodontal defects. J Periodontol 2005;76:890‐898.

1 December 2000 in Journal of Periodontology
Verified
Journal Article
Closed access
KOKazuhiro Okuda
Kazuhiro Okuda
MMManabu Momose
Manabu Momose
AMAkira Miyazaki
Akira Miyazaki
MMMasashi Murata
Masashi Murata
SYShigeru Yokoyama
Shigeru Yokoyama
HYHiromasa Yoshie
Hiromasa Yoshie
Background: There is limited information available from clinical trials regarding the performance of enamel matrix derivative (EMD) in the treatment of periodontal intrabony defects. This randomized, double‐blind, placebo‐controlled, split‐mouth study was designed to compare the clinical and radiographical effects of EMD treatment to that of placebo‐controlled treatment for intrabony defects.Methods: Sixteen patients were included, each of whom had 1 or 2 pairs of intrabony defects located contralaterally in the same arch. Thirty‐six intrabony defects were randomly assigned treatment with flap surgery plus EMD or flap surgery plus placebo. At baseline and at the 12‐month follow‐up evaluation visit, clinical and radiographic measurements were determined. Data were statistically analyzed using the Wilcoxon‐signed rank test (α = 0.05).Results: At the 12‐month visit, bleeding on probing for the EMD group was 0.11 ± 0.32 compared to the placebo group, 0.61 ± 0.50 (P <0.05). Probing depth reduction was greater in the EMD group (3.00 ± 0.97 mm) compared to the placebo group (2.22 ± 0.81 mm) (P <0.05). Mean values for clinical attachment gain in the EMD and the placebo groups were 1.72 ± 1.07 mm and 0.83 ± 0.86 mm, respectively (P <0.05). Vertical relative attachment gain was 38.5 ± 22.6% in the EMD group and 21.4 ± 25.2% in the placebo group (P <0.05). Radiographic bone density gain was greater in the EMD (20.2 ± 16.6%) compared to the placebo group (−3.94 ± 23.3%) (P <0.01).Conclusions: Treatment with flap surgery and EMD, compared to flap surgery with placebo, produced a significantly more favorable clinical improvement in intrabony periodontal defects. J Periodontol 2000;71:1821‐1828.

1 October 2001 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
KOKazuhiro Okuda
Kazuhiro Okuda
AMAkira Miyazaki
Akira Miyazaki
MMManabu Momose
Manabu Momose
MMMasashi Murata
Masashi Murata
TNTakashi Nomura
Takashi Nomura
HYHiromasa Yoshie
Hiromasa Yoshie

17 September 2019 in Journal of Functional Biomaterials
Verified
Journal Article
Open access
PDF file
TTTetsuhiro Tsujino
Tetsuhiro Tsujino
HMHideo Masuki
Hideo Masuki
MNMasayuki Nakamura
Masayuki Nakamura
KIKAZUSHIGE ISOBE
KAZUSHIGE ISOBE
HKHideo Kawabata
Hideo Kawabata
Tomoyuki KawaseTomoyuki Kawase
Tomoyuki Kawase
Compared with platelet-rich plasma, the preparation of platelet-rich fibrin (PRF) is simple and has not been overly modified. However, it was recently demonstrated that centrifugation conditions influence the composition of PRF and that silica microparticles from silica-coated plastic tubes can enter the PRF matrix. These factors may also modify platelet distribution. To examine these possibilities, we prepared PRF matrices using various types of blood-collection tubes (plain glass tubes and silica-containing plastic tubes) and different centrifugation speeds. The protocols of concentrated growth factors and advanced-PRF represented high- and low-speed centrifugation, respectively. Platelet distribution in the PRF matrix was examined immunohistochemically. Using low-speed centrifugation, platelets were distributed homogeneously within the PRF matrix regardless of tube types. In high-speed centrifugation, platelets were distributed mainly on one surface region of the PRF matrix in glass tubes, whereas in silica-coated tubes, platelet distribution was commonly more diffusive than in glass tubes. Therefore, both blood-collection tube types and centrifugal conditions appeared to influence platelet distribution in the PRF matrix. Platelets distributed in the deep regions of the PRF matrix may contribute to better growth factor retention and release. However, clinicians should be careful in using silica-coated tubes because their silica microparticles may be a health hazard.

Verified
Journal Article
Open access
PDF file
HAHachidai Aizawa
Hachidai Aizawa
TTTetsuhiro Tsujino
Tetsuhiro Tsujino
TWTaisuke Watanabe
Taisuke Watanabe
KIKAZUSHIGE ISOBE
KAZUSHIGE ISOBE
YYutaka Kitamura
Yutaka Kitamura
Tomoyuki KawaseTomoyuki Kawase
Tomoyuki Kawase
Platelet-rich fibrin (PRF) is a fibrin matrix enriched with platelets. The PRF matrix is thought to form a steep gradient of platelet density around the region corresponding to the buffy coat in anticoagulated blood samples. However, this phenomenon has not yet been proven. To visualize platelet distribution in PRF in a non-invasive manner, we utilized near-infrared (NIR) imaging technology. In this study, four types of PRF matrices, bio-PRF, advanced-PRF (A-PRF), leukocyte-rich PRF (L-PRF), and concentrated growth factors (CGF) were compared. Blood samples collected from healthy, non-smoking volunteers were immediately centrifuged using four different protocols in glass tubes. The fixed PRF matrices were sagittally divided into two equal parts, and subjected to modified immunohistochemical examination. After probing with NIR dye-conjugated secondary antibody, the CD41+ platelets were visualized using an NIR imager. In L-PRF and CGF, platelets were distributed mainly on and below the distal surface, while in bio-PRF and A-PRF, platelet distribution was widespread and homogenous. Among three regions of the PRF matrices (upper, middle, and lower), no significant differences were observed. These findings suggest that platelets aggregate on polymerizing fibrin fibers and float up as a PRF matrix into the plasma fraction, amending the current “gradient” theory of platelet distribution.